About this trial
Diabetes( mainly type II diabetes )lead to the central nervous system (CNS) function impairment, especially the mild cognitive impairment that increased the risk of progression to dementia.The primary objectives are defined according to a hierarchical design: i) to tailor and apply multi-parametric, functional MRI techniques to identify cerebral abnormalities (cerebral biomarkers) in type 2 diabetes mellitus and prodromal diabetes mellitus ; ii) to assess whether these cerebral biomarkers are associated with cognitive decrements;iii) to follow up with the putative prediabetic condition patients to verify whether they can transform into diabetes.
Eligibility criteria
Qualifiers
without dementia
Inform Consent Form
Education time more than 6 years
blood glucose matches the group standard
Disqualifiers
Pregnant woman
suffer from serious brain disease
Magnetic resonance contraindications
lack of compliance
Trial design
Treatments tested in this trial
- Not listed